108 related articles for article (PubMed ID: 10414118)
1. [Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy].
Feldmann B; Lang GE; Arnavaz A; Jehle PM; Böhm BO; Lang GK
Ophthalmologe; 1999 May; 96(5):300-5. PubMed ID: 10414118
[TBL] [Abstract][Full Text] [Related]
2. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
3. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.
Frystyk J; Bek T; Flyvbjerg A; Skjaerbaek C; Ørskov H
Diabet Med; 2003 Apr; 20(4):269-76. PubMed ID: 12675639
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
Öberg D; Salemyr J; Örtqvist E; Juul A; Bang P
Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
[TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
Loukovaara S; Immonen IJ; Koistinen R; Rutanen EM; Hiilesmaa V; Loukovaara M; Kaaja RJ
J Diabetes Complications; 2005; 19(5):297-304. PubMed ID: 16112506
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
8. Association between serum free IGF-I and IGFBP-3 levels in type-I diabetes patients affected with associated autoimmune diseases or diabetic complications.
Capoluongo E; Pitocco D; Santonocito C; Concolino P; Santini SA; Manto A; Lulli P; Ghirlanda G; Zuppi C; Ameglio F
Eur Cytokine Netw; 2006 Sep; 17(3):167-74. PubMed ID: 17194636
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor-I in diabetic retinopathy.
Payne JF; Tangpricha V; Cleveland J; Lynn MJ; Ray R; Srivastava SK
Mol Vis; 2011; 17():2318-24. PubMed ID: 21921983
[TBL] [Abstract][Full Text] [Related]
10. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
[TBL] [Abstract][Full Text] [Related]
11. Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy.
Janssen JA; Lamberts SW
Clin Endocrinol (Oxf); 2000 Jan; 52(1):1-9. PubMed ID: 10651746
[TBL] [Abstract][Full Text] [Related]
12. Interaction between glycaemic control and serum insulin-like growth factor 1 on the risk of retinopathy in type 2 diabetes.
Chen HS; Wu TE; Hsiao LC; Lin SH
Eur J Clin Invest; 2012 Apr; 42(4):447-54. PubMed ID: 22050075
[TBL] [Abstract][Full Text] [Related]
13. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects.
Gibson JM; Westwood M; Lauszus FF; Klebe JG; Flyvbjerg A; White A
Diabetes; 1999 Feb; 48(2):321-6. PubMed ID: 10334308
[TBL] [Abstract][Full Text] [Related]
15. Increased serum IGF-I during pregnancy is associated with progression of diabetic retinopathy.
Lauszus FF; Klebe JG; Bek T; Flyvbjerg A
Diabetes; 2003 Mar; 52(3):852-6. PubMed ID: 12606530
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus.
Cinaz P; Kendirci M; Kurtoglu S; Gökçora N; Buyan N; Yavuz I; Demir A
J Pediatr Endocrinol Metab; 1996; 9(4):475-82. PubMed ID: 8910817
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBP-1, -2 and -3) in diabetic pregnancy: relationship to macrosomia.
Yan-Jun L; Tsushima T; Minei S; Sanaka M; Nagashima T; Yanagisawa K; Omori Y
Endocr J; 1996 Apr; 43(2):221-31. PubMed ID: 9026269
[TBL] [Abstract][Full Text] [Related]
18. Somatomedin-C (SM-C). Study in diabetic patients with and without retinopathy.
Nardelli GM; Guastamacchia E; Di Paolo S; Balice A; Rosco M; Santoro G; Lollino G; Giorgino R
Acta Diabetol Lat; 1989; 26(3):217-24. PubMed ID: 2694716
[TBL] [Abstract][Full Text] [Related]
19. IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy.
Lee HC; Lee KW; Chung CH; Chung YS; Lee EJ; Lim SK; Kim KR; Huh KB; Lee SC; Kwon OW
Diabetes Res Clin Pract; 1994 Jun; 24(2):85-8. PubMed ID: 7956713
[TBL] [Abstract][Full Text] [Related]
20. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
